Study Summary
This trial is testing a new brain stimulation treatment to help veterans with multiple mental disorders. The treatment is designed to improve problem solving and adaptive cognition.
- Depression
- Repetitive Transcranial Magnetic Stimulation
- Psychosocial Disability
- Post Traumatic Stress Disorder
- Mental Health
- Anxiety
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 4 Secondary · Reporting Duration: 4 weeks post-treatment
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
10 Treatment Groups
Dose 8
1 of 10
Dose 10
1 of 10
Dose 2
1 of 10
Dose 1
1 of 10
Dose 9
1 of 10
Dose 6
1 of 10
Dose 7
1 of 10
Dose 5
1 of 10
Dose 3
1 of 10
Dose 4
1 of 10
Experimental Treatment
50 Total Participants · 10 Treatment Groups
Primary Treatment: Repetitive Transcranial Magnetic Stimulation (rTMS) · No Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 60 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| South Carolina | 100.0% |
What site did they apply to?
| Ralph H. Johnson VA Medical Center, Charleston, SC | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "I have chronic depression ptsd anxiety add with suicidal ideation"
How many prior treatments have patients received?
| 3+ | 100.0% |
Frequently Asked Questions
How many participants are accepted for this medical research initiative?
"Affirmative. Clinicaltrials.gov indicates that this clinical exploration, which was initially advertised on February 1st 2019, is actively looking for volunteers. There is a need to enlist 50 patients from one particular site." - Anonymous Online Contributor
What is the criteria for enrollment in this trial?
"This trial is searching for 50 people aged 18-60 who suffer from depression. To be eligible, applicants must meet this criteria." - Anonymous Online Contributor
Is enrollment for this trial still open to the public?
"Per the clinicaltrials.gov website, this research is still in progress and actively seeking participants. The initial posting date was February 1st 2019 with a most recent update occurring on September 15th 2022." - Anonymous Online Contributor
Is Repetitive Transcranial Magnetic Stimulation (rTMS) sanctioned by the FDA?
"Our team at Power rated the safety of Repetitive Transcranial Magnetic Stimulation (rTMS) as a 1 since this is a Phase 1 trial. Thus, there are only preliminary findings that suggest its efficacy and protection from hazards." - Anonymous Online Contributor
Is the age threshold for this research limited to 30 years or above?
"The eligibility criteria for this medical trial requires that potential participants are aged between 18 and 60 years. Those younger than 18 have access to 261 trials, while those older than 65 can choose from 1,226 other studies." - Anonymous Online Contributor
What is the primary objective of this research endeavor?
"This trial's primary endpoint is to accurately assess patients' psychosocial functioning over a 4-week period. Secondary endpoints include the Mood and Anxiety Symptom Questionnaire (MASQ), which uses a five point Likert scale ranging from "not at all" to "extremely", the Inventory of Depression and Anxious Symptoms (IDAS-II) with responses scored between 1 and 5, and the Hamilton Scale for Depression (HAM-D). This latter assessment entails eight items rated on a 0 - 4 scale while nine are ranked from 0 - 2. Results can range in severity from mild to severe." - Anonymous Online Contributor